September 18-20, 2017
Ocean Place Resort, Long Branch, NJ

2016 Advisory Committee

Anonymous
API Manufacturing
Eli Lilly and Company

Ray Forslund
Senior Director, Project Management
Laurus Synthesis

Rajiv Ginde
Associate Director, NA Strategic Procurement, Finished Dosage Forms
Sandoz Inc.

Rob Goodnow
Director of the Discovery Sciences Chemical Innovation Centre (CIC)
AstraZeneca

Roger Hanselmann
Director of Process Research & Development
Akebia Therapeutics, Inc.

William Leong
Senior Director, CMC
Newron Pharmaceuticals

Chuk Man
Senior Scientist, Medicinal Chemistry
Boehringer-Ingelheim Pharmaceuticals

Robert Mills
VP, CMC
Intrexon Corporation

Deborah Minor, Ph.D.
President
Drug Discovery Alliances, Inc.

Tom Niemeyer
Head, Chemical R&D Global External Supply
Pfizer

Maxwell Reeve
Director Drug Substance Development
Melinta Therapeutics

Surendra Singh
Director Drug Substance
Verastem, Inc.

Richland Tester
Senior Manager Medicinal Chemistry
Celgene Avilomics Research

James Tornos
Director, PharmaTX Research Scientific Services
Pfizer

Tom Wagler
Senior Director, CMC Development
Infinity Pharmaceuticals

Winston Wu
VP, Chemical Development
Lexicon Pharmaceuticals

Scott Zook
Director CMC
Neurocrine Biosciences

Angelos Dovletoglou
Executive Director of Preclinical Development Sciences and Acting Head of Regulatory Affairs
Epizyme